Nektar TherapeuticsNKTRNASDAQ
Loading
PB Ratio: Discounted ValuationCompressed
Percentile Rank64
3Y CAGR+90.2%
5Y CAGR+23.0%
Studio
Year-over-Year Change

Price-to-book ratio

3Y CAGR
+90.2%/yr
vs -23.9%/yr prior
5Y CAGR
+23.0%/yr
Recent acceleration
Acceleration
+114.2pp
Accelerating
Percentile
P64
Within normal range
vs 5Y Ago
2.8x
Strong expansion
Streak
2 yr
Consecutive growthCompressed
PeriodValueYoY Change
20257.94+152.2%
20243.15+284.0%
20230.82-28.9%
20221.15-68.3%
20213.64+29.3%
20202.82+4.8%
20192.69-22.0%
20183.45-96.7%
2017106.04+445.7%
201619.43-